Latest progress in the study of nanoparticle-based delivery of the CRISPR/Cas9 system
•CRISPR/Cas9 system has been used for gene editing in basic research and clinical applications.•A number of CRISPR/Cas9 vehicles including lipofectamine, viruses, and nanoparticles exist.•Different CRISPR/Cas9 delivery systems face numerous challenges during their applications.•We focus on the nanop...
Gespeichert in:
Veröffentlicht in: | Methods (San Diego, Calif.) Calif.), 2021-10, Vol.194, p.48-55 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •CRISPR/Cas9 system has been used for gene editing in basic research and clinical applications.•A number of CRISPR/Cas9 vehicles including lipofectamine, viruses, and nanoparticles exist.•Different CRISPR/Cas9 delivery systems face numerous challenges during their applications.•We focus on the nanoparticle delivery of CRISPR/Cas9 due to its safety, simplicity and flexibility.
The CRISPR/Cas9 system has been harnessed to cleave a targeted DNA fragment via its Cas nuclease activity under the direction of guide RNA for rendering gene insertions, deletions, and point mutations in basic research and clinical applications. There are a number of vehicles, including lipofectamine, viruses, and nanoparticles, that can deliver the CRISPR/Cas9 system, but all these methods face numerous challenges during their application in life science contexts. Here, we focus on the delivery of CRISPR/Cas9 via nanoparticles because this method has shown great advantages in terms of safety, simplicity and flexibility. |
---|---|
ISSN: | 1046-2023 1095-9130 |
DOI: | 10.1016/j.ymeth.2021.06.004 |